Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)

Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication is to ensure that patients receive optimal treatment and are neither overtreated nor undertreated, thereby improving patient outcomes overall. Patients with EC can be categorized into prognostic risk groups based on clinicopathologic findings. Other than tumor type and grade, groupings and recommended management algorithms may take into account age, body mass index, stage, and presence of lymphovascular space invasion. The molecular classification of EC that has emerged from the Cancer Genome Atlas (TCGA) study provides additional, potentially superior, prognostic information to traditional histologic typing and grading. This classifier does not, however, replace clinicopathologic risk assessment based on parameters other than histotype and grade. It is envisaged that molecular and clinicopathologic prognostic grouping systems will work better together than either alone. Thus, while tumor typing and grading may be superseded by a classification based on underlying genomic abnormalities, accurate assessment of other pathologic parameters will continue to be key to patient management. These include those factors related to staging, such as depth of myometrial invasion, cervical, vaginal, serosal surface, adnexal and parametrial invasion, and those independent of stage such as lymphovascular space invasion. Other prognostic parameters will also be discussed. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project.

[1]  E. Oliva,et al.  Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[2]  M. Plante,et al.  Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. , 2017, Gynecologic oncology.

[3]  H. Putter,et al.  Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  A. Malpica,et al.  Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods , 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  N. Hiraoka,et al.  Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma , 2017, The American journal of surgical pathology.

[6]  C. Sessa,et al.  Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers). , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  A. Fader,et al.  Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.

[8]  A. Talhouk,et al.  Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer , 2017, Cancer.

[9]  C. Gilks,et al.  Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma , 2017, The American journal of surgical pathology.

[10]  M. Leitao,et al.  Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma , 2016, Annals of Surgical Oncology.

[11]  H. Putter,et al.  Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts , 2016, Clinical Cancer Research.

[12]  J. Ledermann,et al.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[13]  A. Malpica,et al.  Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma. , 2015, Human pathology.

[14]  T. Bosse,et al.  Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials. , 2015, European journal of cancer.

[15]  Richard G. Moore,et al.  Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. , 2015, Journal of the National Cancer Institute.

[16]  M. Plante,et al.  Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. , 2015, Gynecologic oncology.

[17]  A. Talhouk,et al.  A clinically applicable molecular-based classification for endometrial cancers , 2015, British Journal of Cancer.

[18]  Richard G. Moore,et al.  Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology/gynecologic oncology group 210 trial , 2015 .

[19]  Yi Kan Wang,et al.  Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality. , 2015, Journal of the National Cancer Institute.

[20]  A. Viale,et al.  Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. , 2015, Journal of the National Cancer Institute.

[21]  M. Munsell,et al.  Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[22]  Roger Stevens,et al.  Gray's Anatomy for Students. , 2015 .

[23]  M. Canis,et al.  [Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer]. , 2015, Bulletin du cancer.

[24]  N. Bourdel,et al.  Les lymphadénectomies dans le cancer de l’endomètre, bilan après 4 ans de pratique, doit-on poursuivre ? , 2015 .

[25]  E. Oliva,et al.  Significance of Lymphovascular Space Invasion in Uterine Serous Carcinoma: What Matters More; Extent or Presence? , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[26]  J. Rabban,et al.  Nongynecologic Metastases to Fallopian Tube Mucosa: A Potential Mimic of Tubal High-grade Serous Carcinoma and Benign Tubal Mucinous Metaplasia or Nonmucinous Hyperplasia , 2015, The American journal of surgical pathology.

[27]  Y. Saga,et al.  Influences of Uterine Adenomyosis on Muscle Invasion and Prognosis of Endometrioid Adenocarcinoma , 2014, International Journal of Gynecologic Cancer.

[28]  K. Matsuo,et al.  Significance of Adenomyosis on Tumor Progression and Survival Outcome of Endometrial Cancer , 2014, Annals of Surgical Oncology.

[29]  R. Zaino Unusual Patterns of Endometrial Carcinoma Including MELF and its Relation to Epithelial Mesenchymal Transition , 2014, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[30]  D. Aoki,et al.  Clinicopathological study on para‐aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer , 2014, The journal of obstetrics and gynaecology research.

[31]  M. Leitao,et al.  Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma , 2014, Histopathology.

[32]  J. Hecht,et al.  Value of additional level sections in the evaluation of lymph nodes for endometrial carcinoma staging. , 2013, American journal of clinical pathology.

[33]  D. Doherty,et al.  Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis , 2013, Pathology.

[34]  R. Barakat,et al.  Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging , 2013, International Journal of Gynecologic Cancer.

[35]  T. Le,et al.  The role of surgery in endometrial cancer. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[36]  R. Barakat,et al.  Tumoral Displacement into Fallopian Tubes in Patients Undergoing Robotically Assisted Hysterectomy for Newly Diagnosed Endometrial Cancer , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[37]  A. Bats,et al.  Sentinel Node Biopsy Upstages Patients with Presumed Low- and Intermediate-risk Endometrial Cancer: Results of a Multicenter Study , 2013, Annals of Surgical Oncology.

[38]  M. Nucci,et al.  Problematic issues in the staging of endometrial, cervical and vulval carcinomas , 2013, Histopathology.

[39]  N. Hacker,et al.  Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[40]  M. Nucci,et al.  Low-grade, Low-stage Endometrioid Endometrial Adenocarcinoma: A Clinicopathologic Analysis of 324 Cases Focusing on Frequency and Pattern of Myoinvasion , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[41]  E. Darai,et al.  The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. , 2012, American journal of obstetrics and gynecology.

[42]  R. Rouzier,et al.  Comparison of Diagnostic Accuracy of Frozen Section with Imprint Cytology for Intraoperative Examination of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Results of Senti-Endo Study , 2012, Annals of Surgical Oncology.

[43]  M. Weller,et al.  CD133 expression is associated with small round blue cell tumour morphology in human CNS neoplasms . , 2011 .

[44]  D. Aoki,et al.  Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome , 2011, Current genomics.

[45]  E. Oliva,et al.  Significant Variation in the Assessment of Cervical Involvement in Endometrial Carcinoma: An Interobserver Variation Study , 2011, The American journal of surgical pathology.

[46]  C. Platell,et al.  Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms , 2011, Cancers.

[47]  B. Clarke,et al.  Histologic Artifacts in Abdominal, Vaginal, Laparoscopic, and Robotic Hysterectomy Specimens: A Blinded, Retrospective Review , 2011, The American journal of surgical pathology.

[48]  M. Stoler,et al.  Cervical Stromal Invasion Predicting Survival in Endometrial Cancer , 2010, Obstetrics and gynecology.

[49]  Yoh Watanabe,et al.  Evaluation of Parametrial Spread in Endometrial Carcinoma , 2010, Obstetrics and gynecology.

[50]  M. Stoler,et al.  The Significance of Tumor Involved Adenomyosis in Otherwise Low-stage Endometrioid Adenocarcinoma , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[51]  C. Feltmate,et al.  Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies , 2010, Modern Pathology.

[52]  I. Hammond,et al.  Coexisting serous carcinoma of the endometrium and the fallopian tube. , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[53]  Young Tae Kim,et al.  Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion , 2010, Journal of Korean medical science.

[54]  C. Stewart,et al.  MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion , 2009, Pathology.

[55]  M. Nucci,et al.  Coexisting Intraepithelial Serous Carcinomas of the Endometrium and Fallopian Tube: Frequency and Potential Significance , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[56]  E. Oliva,et al.  Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. , 2009, Gynecologic oncology.

[57]  W. Creasman Revised FIGO staging for carcinoma of the endometrium , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[58]  S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[59]  M. Parmar,et al.  Lymphadenectomy in endometrial cancer – Authors' reply , 2009, The Lancet.

[60]  M. Bernardini,et al.  Issues surrounding lymphadenectomy in the management of endometrial cancer , 2009, Journal of surgical oncology.

[61]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[62]  D. Bodurka,et al.  Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Jamie Weydert,et al.  Mandatory Second Opinion in Surgical Pathology Referral Material: Clinical Consequences of Major Disagreements , 2008, The American journal of surgical pathology.

[64]  R. Barakat,et al.  Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? , 2008, American journal of obstetrics and gynecology.

[65]  M. Bernardini,et al.  Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. , 2007, Annals of diagnostic pathology.

[66]  M. Bernardini,et al.  Adenomyosis is Associated With Myometrial Invasion by FIGO 1 Endometrial Adenocarcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[67]  R. Soslow,et al.  Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[68]  A. Berchuck,et al.  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology , 2006 .

[69]  R. Bentley,et al.  Transtubal Spread of Serous Adenocarcinoma of the Endometrium: An Underrecognized Mechanism of Metastasis , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[70]  L. Hirschowitz,et al.  Assessment of Uterine Wall Thickness and Position of the Vascular Plexus in the Deep Myometrium: Implications for the Measurement of Depth of Myometrial Invasion of Endometrial Carcinomas , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[71]  J. McKenney,et al.  Endometrial Adenocarcinoma Associated With Subtle Lymph-Vascular Space Invasion and Lymph Node Metastasis: A Histologic Pattern Mimicking Intravascular and Sinusoidal Histiocytes , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[72]  I. Jacobs,et al.  Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. , 2004, Gynecologic oncology.

[73]  R. Scully,et al.  Unusual Epithelial and Stromal Changes in Myoinvasive Endometrioid Adenocarcinoma: A Study of Their Frequency, Associated Diagnostic Problems, and Prognostic Significance , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[74]  T. Iwasaka,et al.  Endometrial Carcinomas With Lymph Node Involvement: Novel Histopathologic Factors for Predicting Prognosis , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[75]  P. Clement,et al.  Endometrial Endometrioid Adenocarcinoma With a Deceptive Pattern of Spread to the Uterine Cervix: A Manifestation of Stage IIB Endometrial Carcinoma Liable to Be Misinterpreted as an Independent Carcinoma or a Benign Lesion , 2003, The American journal of surgical pathology.

[76]  I. Ackerman,et al.  Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. , 2003, Gynecologic oncology.

[77]  M. Yen,et al.  Parametrial tumor spreading patterns in cervix cancer patients treated by radical hysterectomy , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[78]  K. Hasegawa,et al.  Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer , 2002, International Journal of Gynecologic Cancer.

[79]  G. Lockwood,et al.  Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. , 2002, International journal of radiation oncology, biology, physics.

[80]  A. Mundt,et al.  The significance of adnexal involvement in endometrial carcinoma. , 1999, Gynecologic oncology.

[81]  M. Tsuneyoshi,et al.  The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. , 1995, Gynecologic oncology.

[82]  K. Barwick,et al.  Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. , 1993, Gynecologic oncology.

[83]  W. Lawrence,et al.  Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases. , 1990, Gynecologic oncology.

[84]  A. Joehlin-Price,et al.  The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas , 2017, The American journal of surgical pathology.

[85]  R. Soslow Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome , 2016, Modern Pathology.

[86]  A. Malpica How to approach the many faces of endometrioid carcinoma , 2016, Modern Pathology.

[87]  R. Rouzier,et al.  Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. , 2015, Gynecologic oncology.

[88]  K. Çetinkaya,et al.  Risk factors of lymph node metastases with endometrial carcinoma. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[89]  E. Oliva,et al.  Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible. , 2013, Gynecologic oncology.

[90]  Sarah J. Johnson,et al.  Standards and datasets for reporting cancers , 2013 .

[91]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[92]  R. Pearcey,et al.  An analysis of the impact of pathology review in gynecologic cancer. , 2000, International journal of radiation oncology, biology, physics.

[93]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .

[94]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.